Huperzine Not classified
No linked studies yet.
$19.95 $0.08 per serving
Product analysis
Huperzine-A 200 mcg offers low-cost huperzine, but its memory-related findings come from people with cognitive illness, leaving its usefulness for healthy adults uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The specific huperzine preparation is not clearly identified. Its absorption quality cannot be judged from the stated amount alone.
Ingredient Transparency63
The huperzine amount is disclosed, but its detailed form is not. That limits comparison with products that identify their preparation.
Value For Money100
The cost is favorable for the amount of huperzine provided. The serving amount makes the ingredient-cost comparison straightforward.
Customer Satisfaction78
Customer ratings are very positive across several hundred reviews. The feedback offers useful satisfaction information without proving cognitive benefits.
Product Focus63
The single ingredient gives the formula a clear connection to memory-related brain signals. Findings from people with cognitive illness do not establish improved cognition or routine brain maintenance in healthy adults.
- Format
Capsule - Container
- 240 Capsule(s)
- Per serving
- $0.08
- Customer rating
- 4.7 · 567 ratings
Goals
Impact
Lower effect
Huperzine · 200 mcg
Impact
Highest effect
Huperzine · 200 mcg
Huperzine affects acetylcholine signalling by inhibiting the enzyme that breaks it down. That mechanism and disease-treatment trials do not establish cognitive enhancement or routine brain maintenance in healthy adults. The 200 mcg serving is fully recognized for amount in the saved findings, without proving a practical cognitive benefit.
How this product is rated for Brain Health
Ingredient fit95
The ingredient selection connects to brain health, with serving amounts and the formula’s wider purpose shaping how focused that connection is.
Goal fit
The formula centers on ingredients connected to brain health, though its intended uses extend beyond this goal.
Dose adequacy
The recognized ingredients reach the saved amount references; those references do not guarantee cognitive benefit.
Pathways54
The strongest saved connection is acetylcholine signalling; this describes the ingredient grouping rather than a demonstrated brain-health outcome. One area reaches the saved coverage threshold, leaving the connection concentrated rather than broad.
Depth
The strongest saved connection is acetylcholine signalling; this describes the ingredient grouping rather than a demonstrated brain-health outcome.
Breadth
One area reaches the saved coverage threshold, leaving the connection concentrated rather than broad.
Evidence90
The saved evidence findings recognize ingredients and preparations, while the supplied scientific context limits expectations for general cognitive improvement.
Evidence strength
Huperzine leads the saved evidence finding, while the supplied research context limits claims of broad cognitive improvement.
Studied preparation
The saved findings recognize the included preparations; this does not establish equivalence where the supplied scientific context distinguishes extracts or populations.
Formulation logic100
The saved findings identify no missing required partners or configured conflicts. Amount recognition does not itself establish an effective cognitive outcome.
Partner coverage
The recognized ingredients have no missing required partner in the saved findings; this does not establish an added benefit from combining them.
Conflicts
No configured conflict was identified. The caffeine-specific checks do not apply because no qualifying caffeine amount is established.
Effective doses
All ingredients included in this finding meet its minimum amount threshold, which is a comparison reference rather than a proven cognitive dose.
Impact
Highest effect
Huperzine · 200 mcg
Huperzine acts on the enzyme that breaks down acetylcholine, a chemical involved in memory. The supplied clinical evidence is from people with mild or moderate Alzheimer disease, so it does not establish routine cognitive enhancement in healthy adults. The declared 200 mcg meets the saved amount comparison, but that comparison does not transfer treatment-cohort results to general use.
How this product is rated for Cognitive Support
Ingredient fit95
Huperzine is the formula's single ingredient connected with cognition.
Goal fit
Huperzine is the formula's single ingredient connected with cognition.
Dose adequacy
The declared amount meets the saved comparison range; healthy-adult benefit is not established by that comparison.
Pathways60
The saved findings place huperzine under acetylcholine signalling.
Depth
The saved findings place huperzine under acetylcholine signalling.
Breadth
One route receives a substantial contribution; broader coverage is limited.
Evidence91
Huperzine's supplied clinical evidence concerns an Alzheimer disease population.
Evidence strength
Huperzine's supplied clinical evidence concerns an Alzheimer disease population.
Studied preparation
The saved preparation finding is positive, with the disease-population distinction retained.
Formulation logic100
The included ingredients need no missing partner, and no configured ingredient conflict was found.
Partner coverage
The included ingredients can contribute independently; no required partner is missing.
Conflicts
No configured caffeine, melatonin or stimulant-amine conflict was found.
Effective doses
All ingredients included in this finding meet its minimum amount comparison; that threshold does not establish clinical effectiveness.
Impact
Lower effect
Huperzine · 200 mcg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Huperzine-A | 200 mcg |
Huperzine · 200 mcg OverallScore63
The serving lists 200 mcg of Huperzine A. The whole-product price works out to about $0.04 per 100 mcg of Huperzine A, which is relatively low.
How this ingredient is rated
Active Ingredient Quality & Bioavailability20
Huperzine A is identified, while its plant source and extract concentration are not established in the saved facts.
Source and Standardization Clarity
Huperzine A is named, but the available facts do not establish the source extract or a standardization percentage.
Dose, Safety & Label Transparency88
The serving lists 200 mcg of Huperzine A. No specific cycling guidance is recorded in the saved facts.
Huperzine A Dosage Efficacy
The serving lists 200 mcg of Huperzine A.
Cycling Guidance and Transparency
The active amount is specified, but no specific cycling guidance is recorded in the saved facts.
Value100
The whole-product price works out to about $0.04 per 100 mcg of Huperzine A, which is relatively low.
Price per 100mcg of Huperzine A
Based on the whole-product price, 100 mcg of Huperzine A costs about $0.04, which is relatively low.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
- Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
- [Drug evaluation of huperzine A in the treatment of senile memory disorders].
- Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.